The rising interest in successful weight management has resulted in considerable investigation into novel treatments. Recently , Retatrutide, a dual -action glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor stimulator, has demonstrated promising results in clinical trials, indicating potential for considerable weight decrease. T